This White Paper from Dassault Systèmes explores how biopharma organisations can use the power of scientific AI to revolutionise R&D operations and accelerate the delivery of life-changing medicines ...

The Trump administration in the United States is considering an executive order to strictly restrict approvals for ...

Looking for low-cost biotech opportunities with big upside? In this video, MarketBeat’s Chris Markoch breaks down 3 speculative biotech stocks trading under $5 — each with significant growth potential ...

Retro Biosciences is set to run a clinical trial for an aging drug designed to reverse Alzheimer's, its CEO Joe Betts-LaCroix ...

Economically, INNOVERA positions tanners to better compete with synthetic materials. While much of the market is flooded with ...